BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 25135793)

  • 1. Addition of recommendations for the use of recombinant human thrombomodulin to the "Expert consensus for the treatment of disseminated intravascular coagulation in Japan".
    Wada H; ; Okamoto K; Iba T; Kushimoto S; Kawasugi K; Gando S; Madoiwa S; Uchiyama T; Mayumi T; Seki Y
    Thromb Res; 2014 Oct; 134(4):924-5. PubMed ID: 25135793
    [No Abstract]   [Full Text] [Related]  

  • 2. A retrospective comparative study of recombinant human thrombomodulin and gabexate mesilate in sepsis-induced disseminated intravascular coagulation patients.
    Takazono T; Nakamura S; Imamura Y; Yoshioka S; Miyazaki T; Izumikawa K; Sawai T; Matsuo N; Yanagihara K; Suyama N; Kohno S
    J Infect Chemother; 2014 Aug; 20(8):484-8. PubMed ID: 24855912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant thrombomodulin and activated protein C in the treatment of disseminated intravascular coagulation.
    Maruyama I
    Thromb Haemost; 1999 Aug; 82(2):718-21. PubMed ID: 10605773
    [No Abstract]   [Full Text] [Related]  

  • 4. Post-marketing surveillance of thrombomodulin alfa, a novel treatment of disseminated intravascular coagulation - safety and efficacy in 1,032 patients with hematologic malignancy.
    Asakura H; Takahashi H; Tsuji H; Matsushita T; Ninomiya H; Honda G; Mimuro J; Eguchi Y; Kitajima I; Sakata Y
    Thromb Res; 2014 Mar; 133(3):364-70. PubMed ID: 24440141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful treatment of disseminated intravascular coagulation in a child with acute myelogenous leukaemia using recombinant thrombomodulin.
    Ogawa E; Yagasaki H; Kato M; Shichino H; Chin M; Mugishima H
    Br J Haematol; 2010 Jun; 149(6):911-2. PubMed ID: 20346017
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy of recombinant human soluble thrombomodulin in severe postpartum hemorrhage with disseminated intravascular coagulation.
    Sugawara J; Suenaga K; Hoshiai T; Sato T; Nishigori H; Nagase S; Yaegashi N
    Clin Appl Thromb Hemost; 2013 Sep; 19(5):557-61. PubMed ID: 22496090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant soluble thrombomodulin as an adjunctive treatment for sepsis and disseminated intravascular coagulation: relatively safe and possibly effective.
    Fink MP
    Crit Care Med; 2013 Sep; 41(9):2221-3. PubMed ID: 23979366
    [No Abstract]   [Full Text] [Related]  

  • 8. ADAMTS-13 activity can predict the outcome of disseminated intravascular coagulation in hematologic malignancies treated with recombinant human soluble thrombomodulin.
    Ohshiro M; Kuroda J; Kobayashi Y; Akaogi T; Kawata E; Uoshima N; Kamitsuji Y; Kaneko H; Shimura K; Shimazaki C; Murakami S; Hatsuse M; Okano A; Kobayashi T; Uchiyama H; Matsumoto Y; Horiike S; Taniwaki M
    Am J Hematol; 2012 Jan; 87(1):116-9. PubMed ID: 21989545
    [No Abstract]   [Full Text] [Related]  

  • 9. Impact of recombinant soluble thrombomodulin (thrombomodulin alfa) on disseminated intravascular coagulation.
    Mimuro J; Takahashi H; Kitajima I; Tsuji H; Eguchi Y; Matsushita T; Kuroda T; Sakata Y
    Thromb Res; 2013 May; 131(5):436-43. PubMed ID: 23566534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Japanese consensus for disseminated intravascular coagulation (DIC): is it a small world after all?
    Levi M
    Thromb Res; 2010 Jan; 125(1):4-5. PubMed ID: 19735937
    [No Abstract]   [Full Text] [Related]  

  • 11. Recombinant soluble thrombomodulin for postoperative disseminated intravascular coagulation.
    Hashimoto D; Chikamoto A; Miyanari N; Ohara C; Kuramoto M; Horino K; Ohshima H; Baba H
    J Surg Res; 2015 Aug; 197(2):405-11. PubMed ID: 25972310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The effect of the recombinant thrombomodulin which merged to hematological malignancy].
    Kawasugi K
    Rinsho Byori; 2011 Feb; Suppl 147():181-7. PubMed ID: 21761769
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical Outcomes of Recombinant Human-soluble Thrombomodulin Treatment for Disseminated Intravascular Coagulation in Solid Tumors.
    Kashiwagi S; Asano Y; Takahashi K; Shibutani M; Amano R; Tomita S; Hirakawa K; Ohira M
    Anticancer Res; 2019 May; 39(5):2259-2264. PubMed ID: 31092417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TAFRO Syndrome with Disseminated Intravascular Coagulation Successfully Treated with Tocilizumab and Recombinant Thrombomodulin.
    Takayama Y; Kubota T; Ogino Y; Ohnishi H; Togitani K; Yokoyama A
    Intern Med; 2018 May; 57(9):1291-1296. PubMed ID: 29279488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Efficacy of recombinant thrombomodulin in septic patients].
    Eguchi Y
    Rinsho Byori; 2011 Feb; Suppl 147():177-80. PubMed ID: 21761768
    [No Abstract]   [Full Text] [Related]  

  • 16. [Thrombomodulin-relationship thrombotic marker and therapeutic effect].
    Nomura S
    Rinsho Byori; 2011 Feb; Suppl 147():188-93. PubMed ID: 21761770
    [No Abstract]   [Full Text] [Related]  

  • 17. [Successful treatment using recombinant thrombomodulin for disseminated intravascular coagulation associated with recurrent prosthetic valve endocarditis].
    Masuda S; Adachi O; Ito K; Matsuo S; Hayatsu Y; Suzuki Y; Saito T; Akiyama M; Kumagai K; Motoyoshi N; Kawamoto S; Saiki Y
    Kyobu Geka; 2013 Feb; 66(2):101-5. PubMed ID: 23381354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Model-based analysis of covariate effects on population pharmacokinetics of thrombomodulin alfa in patients with disseminated intravascular coagulation and normal subjects.
    Tsuruta K; Yamada Y; Serada M; Tanigawara Y
    J Clin Pharmacol; 2011 Sep; 51(9):1276-85. PubMed ID: 21098690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant Thrombomodulin Used to Successfully Treat Cronkhite-Canada Syndrome with Disseminated Intravascular Coagulation due to Sepsis in a Compromised Patient.
    Morino K; Honma Y; Kumei S; Watanabe T; Kume K; Yoshikawa I; Harada M
    Intern Med; 2018 Nov; 57(21):3079-3085. PubMed ID: 29877275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombomodulin alfa treatment in patients with acute promyelocytic leukemia and disseminated intravascular coagulation: a retrospective analysis of an open-label, multicenter, post-marketing surveillance study cohort.
    Matsushita T; Watanabe J; Honda G; Mimuro J; Takahashi H; Tsuji H; Eguchi Y; Kitajima I; Sakata Y
    Thromb Res; 2014 May; 133(5):772-81. PubMed ID: 24636871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.